To further support our findings, we used two sequence-independent short hairpin RNA (shRNA) constructs to genetically knock down ATAD2 expression and examined the effect of ATAD2 knockdown on ovarian cancer growth using the soft-agar assay. Here, ATAD2 is linked to ovarian carcinoma.